The Board of Directors of MAIA Biotechnology, Inc. has authorized a buyback plan on September 28, 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.3 USD | -0.30% | +8.20% | +182.05% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+182.05% | 68.12M | |
+43.53% | 50.93B | |
-0.51% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+13.21% | 26.02B | |
-21.93% | 18.9B | |
+7.68% | 13.21B | |
+24.07% | 12.17B | |
+30.15% | 12.16B |
- Stock Market
- Equities
- MAIA Stock
- News MAIA Biotechnology, Inc.
- MAIA Biotechnology, Inc. authorizes a Buyback Plan.